Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
17th October 2013
Initial Evidence in Thromboangiitis Obliterans (Buerger’s Disease) Treatment with Bosentan
Thromboangiitis obliterans (TAO) is a vascular disease that affects small and medium-sized arteries and veins of both upper and lower extremities. Distal…
17th October 2013
Nationwide Family Studies of Cardiovascular Diseases - Clinical and Genetic Implications of Family History
Studies of family history (FH) have long been used to estimate the heritability of cardiovascular diseases (CVDs). Genome-wide association studies (GWAS)…
17th October 2013
The Benefits of Rivaroxaban (Xarelto®) Across Multiple Indications and the Relevance to Cardiologists
Oral anticoagulation with vitamin-K-antagonists has well known limitations and requires routine clinical monitoring of coagulation parameters. The new…
1st October 2013
Poor Asthma Control, Device Handling and Phenotype
The aim of this symposium is to discuss the impact of poor treatment and poor inhaler technique on asthma outcomes. In addition, the symposium will…
1st October 2013
Long-Term Non-Invasive Ventilation (NIV) for COPD Patients with Chronic Respiratory Failure
Chronic obstructive pulmonary disease (COPD) is a major health issue worldwide, with disease burden, healthcare costs, and mortality rates all…
1st October 2013
Effectiveness of Inhaler Devices in Adult Asthma and COPD
Inhalation therapy remains the cornerstone of treatment for bronchial diseases. Despite being pharmacologically efficacious, currently available inhaled…
1st October 2013
Bronchoscopic Nitinol Coil Implantation: A New Lung Volume Reduction Strategy in COPD
Emphysema is a progressive, debilitating disease characterised by irreversible destruction of lung tissue. The gas trapping within the destroyed alveoli…
1st October 2013
COPD Nocturnal Desaturator Patients with Obesity and Pulmonary Hypertension: Cross-Talk Between Adipocyte Tissue Systemic Hypoxia and Lung-To-Blood Translocation of Inflammatory Mediators
Chronic obstructive pulmonary disease (COPD) is often accompanied by other chronic diseases associated with systemic inflammation, such as chronic heart…
1st October 2013
Bronchial Allergen Challenges in Asthma Research
In the development of new antiallergic or antiasthmatic therapies, mouse models have helped to identify novel therapeutic agents. Before a medication is…
1st October 2013
Asthma in Pregnancy
Asthma is a common disease among pregnant women. Uncontrolled asthma may increase the risk of maternal and foetal complications, thus optimal asthma…
←
1
2
3
…
147
148
149
150
151
152
153
→